Autre Publication Scientifique Année : 2022

Inhibition and overexpression of DiPRO1/ZNF555 distinctly modulates the transcriptome of human myoblasts, rhabdomyosarcoma and Ewing sarcoma cells

Résumé

DATASET: The stable overexpression or downregulation of ZNF555 transcripts was achieved by the generation of stable cell lines using lentivirus (pKLO_shZNF555) or retrovirus vectors (pOZ_FHHY_ZNF555). Non-malignant immortalised myoblasts and malignant TE671 and A673 cell lines used in this study. Iryna Pirozhkova. "Inhibition and overexpression of DiPRO1/ZNF555 distinctly modulates the transcriptome of human myoblasts, rhabdomyosarcoma and Ewing sarcoma cells." BioStudies, E-MTAB-10822, 2022, https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-10822.

HAL

Cite hal-04697294 Article Jeremy Rich, Melanie Bennaroch, Laura Notel, Polina Patalakh, Julien Alberola, et al.. DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells. EMBO Molecular Medicine, 2024, 16 (8), pp.1840-1885. ⟨10.1038/s44321-024-00097-z⟩. ⟨hal-04697294⟩

Fichier non déposé

Dates et versions

hal-05045552 , version 1 (24-04-2025)

Identifiants

  • HAL Id : hal-05045552 , version 1

Citer

Iryna Pirozhkova. Inhibition and overexpression of DiPRO1/ZNF555 distinctly modulates the transcriptome of human myoblasts, rhabdomyosarcoma and Ewing sarcoma cells. 2022. ⟨hal-05045552⟩

Collections

49 Consultations
0 Téléchargements

Partager

  • More